Donate Today
Support our mission to empower families, enhance awareness, educate healthcare experts, and propel research forward. Your contribution, whether big or small, plays a vital role in our journey!
Your generous one-time gift or continued monthly support helps fund essential activities such as public awareness campaigns and ongoing research like Action for LMNA. Your donation truly makes an impact!
Your generous one-time gift or continued monthly support helps fund essential activities such as public awareness campaigns and ongoing research like Action for LMNA. Your donation truly makes an impact!
About Action for LMNA
The lamin A/C gene mutation, a change deep within our genetic code, carries a profound impact on heart health, presenting a significant challenge for individuals and families alike. This mutation, which leads to a serious heart condition, has a startling 50% chance of being passed down from parent to child, coupled with a high penetrance rate, meaning if you have the mutation, there's a very high likelihood of developing the disease. This condition gravely affects the heart's ability to function properly, often leading to heart failure and other severe complications. It's a relentless condition that not only affects those diagnosed today but also poses a serious risk for future generations.
In the face of this daunting health issue, hope shines through in the form of a groundbreaking study led by Rogier Veltrop and Maastricht University. This unique research involves a family spanning three generations, encompassing males and females, individuals with and without the genetic mutation, and both symptomatic and asymptomatic members. The study aims to uncover the intricacies of DNA processing in cells affected by the LMNA mutation. This insight is crucial for developing innovative treatments, aligning with the pioneering efforts at CARIM, Maastricht University's renowned cardiovascular disease research school.
This family study is a pivotal step towards creating genetic corrections and therapies. It offers an unparalleled opportunity to gain valuable insights from a family sharing the same genetic makeup, providing accurate and reliable data.
These projects are set to launch, with the initial phase of cell reprogramming and characterization requiring approximately €40,000. The subsequent research phase will need an additional €100,000 to unearth new molecular mechanisms and jump start groundbreaking gene therapies for LMNA patients.
We now reach out to you, our supportive community, to help realize this project. The LMNA Cardiac patient organization is already contributing significantly to this cause. Your recurring monthly donations can significantly accelerate this essential research, offering new hope and groundbreaking solutions for those impacted by this heart condition.
Your support, regardless of size, is crucial not only for funding this vital research but also for raising awareness and drawing us closer to a pivotal discovery. Together, we can tackle this heart health challenge and forge a path to a healthier future for those affected by this condition.
Join us in this vital endeavor. Your support can be the key to transforming the lives of those living with this heart condition, offering hope and a chance for a healthier tomorrow.
In the face of this daunting health issue, hope shines through in the form of a groundbreaking study led by Rogier Veltrop and Maastricht University. This unique research involves a family spanning three generations, encompassing males and females, individuals with and without the genetic mutation, and both symptomatic and asymptomatic members. The study aims to uncover the intricacies of DNA processing in cells affected by the LMNA mutation. This insight is crucial for developing innovative treatments, aligning with the pioneering efforts at CARIM, Maastricht University's renowned cardiovascular disease research school.
This family study is a pivotal step towards creating genetic corrections and therapies. It offers an unparalleled opportunity to gain valuable insights from a family sharing the same genetic makeup, providing accurate and reliable data.
These projects are set to launch, with the initial phase of cell reprogramming and characterization requiring approximately €40,000. The subsequent research phase will need an additional €100,000 to unearth new molecular mechanisms and jump start groundbreaking gene therapies for LMNA patients.
We now reach out to you, our supportive community, to help realize this project. The LMNA Cardiac patient organization is already contributing significantly to this cause. Your recurring monthly donations can significantly accelerate this essential research, offering new hope and groundbreaking solutions for those impacted by this heart condition.
Your support, regardless of size, is crucial not only for funding this vital research but also for raising awareness and drawing us closer to a pivotal discovery. Together, we can tackle this heart health challenge and forge a path to a healthier future for those affected by this condition.
Join us in this vital endeavor. Your support can be the key to transforming the lives of those living with this heart condition, offering hope and a chance for a healthier tomorrow.